Paroxysmal nocturnal hemoglobinuria (PNH)
is a rare chronic hemolytic anemia characterized by an acquired defect of the erythrocyte which renders it susceptible to hemolysis by normal human serum. Previous reports have indicated that magnesium and factors resembling the components of complement are required for the hemolysis in vitro of PNH erythrocytes by normal serum (1, 2) .
Recently a naturally occurring serum protein, properdin, has been described which requires magnesium and complement for its activity in vitro (3) . Thus, properdin, magnesium, and complement have been termed the properdin system, which participates in the lysis of certain bacteria and the inhibition of certain viruses (4, 5) .
The resemblance between the factors required for PNH hemolysis and the constituents of the properdin system prompted this study on the role of the properdin system in the hemolysis of PNH erythrocytes.
METHODS
The test system in all instances was the hemolysis of PNH erythrocytes obtained from three patients with typical PNH whose case histories will be reported elsewhere (6) . The red blood cells from all three patients had similar characteristics.
Erythrocytes from oxalated or defibrinated blood were washed three times in isotonic sodium chloride and resuspended to a concentration of 50 per cent in isotonic sodium chloride containing 0.0005 M magnesium chloride. They were stored at 4°C and discarded after 5 days.
Sera: Fresh, clotted venous blood was allowed to re- ' 25°C) and then stored overnight at 40C. Serum was separated from the clot by centrifugation and stored at 4°C. On storage at 4°C serum loses its ability to hemolyze PNH erythrocytes in several days; therefore all sera were used within three days of collection. Serum, however, can be stored at -70°C for at least six months without loss of hemolytic activity. Serum was diluted with isotonic sodium chloride containing 0.0005 M magnesium chloride.
Heated serum was prepared by heating in a 56°C water bath for 30 minutes. Properdin is inactivated in such serum (3) .
Hemi,olytic system: Except wvhere indicated all tests were conducted in a buffered system at pH 6.8 to 6.9.
Since minor variations in pH have been noted to result in marked changes in degree of hemolysis, a well buffered system is essential. The buffer was made by dissolving 3.4 gm. of imidazole in 90 ml. of 0.2 M hydrochloric acid, and adding distilled water to 100 ml. This was titrated to pH 6.7 with approximately 0.2 volumes of normal hydrochloric acid (7) . All sera were acidified and buffered after heating or other pre-treatment. The addition of 0.1 volume of 0.145 MI hydrochloric acid and 0.1 volume of the buffer to one volume of serum, followed by 0.1 volume of the 50 per cent erythrocyte suspension resulted in a stable final pH of 6.8 to 6.9. The mixture was incubated for 15 minutes at 37°C in a water bath. After incubation and centrifugation, hemolysis was scored by inspection on a scale of 0 to +++, or the free hemoglobin was determined quantitatively on an Evelyn photoelectric colorimeter to obtain per cent hemolysis. Changes in the number of transfused cells present in patient's cell population caused the variations in hemolysis observed in different experiments.
Special serumiii Preparations: Serum samples from which components of complement, C'1, C'2, C'3, or C'4 had been removed, referred to respectively as RI, R2, R3, and R4, were prepared as previously described (8) .
Properdin was removed from serum by exposing it to zymosan at 17°C (3). Serum rendered deficient of properdin by this means is called RP. It contains all measurable factors of the clotting system and all components of complement in amounts comparable to untreated serum. The RP used in these studies was required to meet the criteria previously established (3, 9) .
Purified properdin was prepared by a method described elsewhere (3 demonstrates that other factors similar to or identical with the components of complement are essential for hemolysis of PNH cells. Although the inactivated sera were prepared by accepted methods, one cannot exclude the possibility that there are removed other unidentified substances unrelated to complement, but required for PNH hemolysis. The ability of properdin obtained from several animal species to restore the human PNH system strengthens the initial hypothesis that this factor is a common and basic constituent of serum. tween properdin level and PNH activity. This inconsistency, presumably due to other limiting variables such as complement components, precludes the use of PNH hemolysis as a means of routine measurement of properdin in serum at this time.
Relation of properdin to the thrombin effect on PNH hemolysis
In normal serum with moderate hemolytic activity for PNH cells, addition of thrombin has been noted to result in increased hemolysis. This has been the basis of a diagnostic test for PNH (11) , and forms an important part of a theory proposed by Crosby relating PNH hemolysis to the clotting system. Accordingly, the possible relationship between thrombin and properdin effect was investigated.
Both commercial and "pure" thrombin (ParkeDavis and Co.) were found to contain properdin activity, varying from one unit to four units of properdin in every 50 units of thrombin, which is the amount used in the thrombin test. Neither properdin nor thrombin was hemolytic alone, but the addition of equivalent amounts of thrombin or properdin to serum resulted in equal augmentation of hemolysis of PNH cells (Table V) Larger amounts of thrombin have an anticomplementary effect on serum and could not be tested.
Comments: The detection of properdin in thrombin preparations andI the evidence that 1) the hemolytic property of thrombin corresponds to its properdin content, and 2) thrombin specifically restores an RP serum to hemolytic activitv, suggest that properdin is the active principle responsible for the effect of thrombin. Accordingly. the activity of thrombin may be due to the addition of properdin contained in thrombin rather than to the inactivation of a proposed inhibitor by thrombin per se. The coexistence of properdin with thrombin in preparations of the latter is not surprising, for both are p3-euglobulins with similar iso-electric points. It was not possible to remove properdin from thrombin preparations with zymosan because of the requirement for magnesium and the components of complement.
DISC USSION
Both complement and the clotting system have been implicated in the hemolysis in vitro of PNH erythrocytes. Originally Ham and Dingle (2) showed that destruction of any component of complement resulted in loss of hemolytic activity of serum, and that addition of guinea pig complement to nornmal serum caused increased hemolysis. However, serum complement did not appear to be depleted during the hemolysis of PNH cells, and subsequent studies indicated that the hemolytic activity of a serum could be destroyed without loss of conventional complement (12) . Thus, complement alone did not appear to be responsible for hemolysis of PNH cells, although factors similar to complement appeared to be necessary for the hemolytic reaction.
Crosby and Dameshek (13) proposed that the PNH hemolytic factor was related to ac-globulin, but Harris, Jordan, Pillemer, and Desforges (1) clearly showed that ac-globulin was not essential for hemolysis of PNH cells. More recently, Crosby (14) has proposed a complex of four accelerators and inhibitors of the PNH system related to the clotting mechanism. This theory had its origin in the observed clinical tendency to thrombosis in patients with PNH, and it is based in large part on the action of thrombin in causing augmentation of PNH hemolysis in vitro. None of the four proposed factors has been identified in support of this theory.
The current study offers evidence that the properdin system, a natural defense mechanism of human serum, is required for PNH hemolysis.
In everN-manner tested the PNH system is coImlparable in requirements and behavior to the reactions of the properdin system with zymosan, bacteria and viruses. All these reactions require magnesiunm and factors indistinguishable from complemiient along with properdin, and all are dependent on a specific temperature and pH.
These observations support the findings of ator of Crosby. Further, properdin activity is probably responsible for the effect observed when thrombin is added to serum. The existence of a heat stable inhibitor which is inactivated by thrombin was proposed on the evidence that augmented hemolysis resulted from addition of thrombin to serum and its subsequent removal by barium sulfate. Since properdin is present in thrombin preparations and is not removed by barium sulfate, the "thrombin effect" could well be due to the addition of properdin, a procedure which has been shown to augment PNH hemolysis. Properdin has no demonstrable relationship to the clotting system, as evidenced by the fact that properdin preparations contain no activity similar to the described clotting factors, and a serum or plasma from which properdin has been removed is normal for known clotting factors when compared to an untreated control (3). Thus, these studies indicate that the properdin system, consisting of properdin, components indistinguishable from complement, and magnesium, is required for the hemolysis of PNH erythrocytes in vitro. The earlier observations on the role of the properdin system in bacterial destruction and virus neutralization (4, 5) and the requirement of properdin for hemolysis in vitro of PNH cells, suggest that hemolysis of PNH erythrocytes may be due to the interaction of properdin with the stroma of the intact erythrocytes. It has already been suggested that the final destruction of PNH cells is due to a proteolytic enzyme system (1), and the relation of properdin to such a system awaits further investigation. SUMMARY 1. Similarities between the factors required for PNH hemolysis and the factors comprising the properdin system are pointed out.
2. Removal of properdin from serum renders the serum inactive for PNH hemolysis but not for immune hemolytic systems; readdition of properdin derived from several species restores PNH hemolytic activity to such serum. 3 . A relationship exists between the PNH hemolytic activities and properdin titers of sera. The addition of properdin to weakly lytic sera also augments hemolysis. 4 . The ability of thrombin to affect PNH hemolysis may be due to the presence of properdin in samples of thrombin.
5. The PNH hemolytic system of normal serum includes properdin, factors resembling the components of complement, and magnesium.
